Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
K. J. Schjoedt
ResearcherPublications, citations & collaboration network
K. J. Schjoedt is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 17 works, 1,808 citations, an h-index of 14 and an i10-index of 15.
17
Works
1,808
Citations
14
h-index
15
i10-index
IDs:OpenAlex
How has K. J. Schjoedt's publication output changed over time?
ScholarIQpublication output · 2004–2010
Output declined50% over the shown period — from 2 works in 2004 to 1 in 2010.
2
3
1
2
1
1
200420052006200820092010
What are the most-cited papers on K. J. Schjoedt?
ScholarIQmost cited works
Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy
Kasper Rossing, K. J. Schjoedt, U. Smidt, Frans Boomsma, Hans‐Henrik Parving
Diabetes Care. 2005299 CitationsOPEN ACCESS
Aldosterone escape during blockade of the renin?angiotensin?aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
K. J. Schjoedt, Steen Andersen, Peter Rossing, Lise Tarnow, Hans‐Henrik Parving
Diabetologia. 2004245 CitationsOPEN ACCESS
Beneficial impact of spironolactone in diabetic nephropathy
K. J. Schjoedt, Kasper Rossing, Tina R. Juhl, Frans Boomsma, Peter Rossing, Lise Tarnow, Hans‐Henrik Parving
Kidney International. 2005239 CitationsOPEN ACCESS
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
Kasper Rossing, K. J. Schjoedt, Berit R. Jensen, Frans Boomsma, Hans‐Henrik Parving
Kidney International. 2005226 Citations
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
K. J. Schjoedt, Kasper Rossing, Tina R. Juhl, Frans Boomsma, Lise Tarnow, Peter Rossing, H.-H. Parving
Kidney International. 2006214 Citations
Related on ScholarIQ
Steno Diabetes Centers
Institution
Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy
Paper
Aldosterone escape during blockade of the renin?angiotensin?aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
Paper
Beneficial impact of spironolactone in diabetic nephropathy
Paper
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
Paper
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
Paper